65,437 trials
Benign Prostatic Hyperplasia · Lower Urinary Tract Symptoms
Primary: Long-term Effectiveness of Prostatic Artery Embolization (PAE) With Embosphere Microspheres as Assessed by the International Prostate Symptom Score (IPSS). — -11.1…
Heart Failure
Primary: The Percentage of Individuals in Each Group With a Significant Decline in the LVEF. — 22; 9 Participants
Smoking, Cigarette · Electronic Cigarettes
Primary: Number of Cigarette Puffs Taken (0 to 20) — 12.1; 10.8 Puffs chosen
Paroxysmal Nocturnal Hemoglobinuria
Primary: Summary of Lactate Dehydrogenase (LDH) Responders — 6; 5; 7; 5 Participants
Malaria
Primary: Area Under the Concentration-time Curve From Hour 0 to the Last Sampling Point (AUC 0-t) for Pyronaridine and Dihydroartemisinin (DHA) — 11640; 11324; 1119; 829 ng*h/ml
HIV
Primary: Number of Participants Reporting Local Reactogenicity Signs and Symptoms Within 7 Days of CAP256V2LS Product Administration — 5; 4; 0; 1 Participants
Diet Modification
Primary: HEI-2015 Total and Component Scores — 61.6; 65.7; 2.1; 2.3 score on a scale — p=1.00
Cervical Intraepithelial Neoplasia
Primary: Number of Subjects With Complete Response With the Intention-to-treat (ITT) Analysis — 12; 20 Participants
Suicide
Primary: Training Acceptability - System Usability Scale for Client Bot Emily — 70.3 score on a scale
Acute Myeloid Leukemia · Myelodysplastic Syndrome · Chronic Myelomonocytic Leukemia
Primary: Number of Participants With Treatment Emergent Adverse Event (AE) and Treatment Related AE — 7; 4; 5; 4 Participants
Pain, Postoperative · Brachial Plexus Block
Primary: Pain Intensity Score at Rest at 24 Hours Post-operatively — 1; 1 units on a scale
Depression, Anxiety
Primary: Message Motivation Ratings — 6.33 units on a scale
Crohn's Disease
Primary: Induction Study: Percentage of Participants Who Achieved Clinical Remission by Crohn's Disease Activity Index (CDAI) at Week 10 — 32.9; 25.7; 19.8; 26.7 percentage of…
Acute Myeloid Leukemia
Primary: Number of Patients Who Relapsed — 5; 2; 0; 1 Participants
Nephrolithiasis
Primary: Satisfaction With Pain Relief — 8.70; 8.85 score on a scale — p=0.70